We represented existing investor Humana, Inc. in its investment in Monogram Health, a benefit management and care delivery company for individuals with chronic kidney and end of stage renal disease. The $160 million Series B funding round led by TPG Capital will be used by Monogram to further solidify its role as the preeminent leader in personalized, compassionate, and evidence-based kidney care for patients.
Monogram Health Completes $160 Million Series B Financing Round
You Also May Be Interested In:
Successful Defense of National Home Healthcare Provider in Appealing $18 Million Extrapolated Overpayment Resulting from UPIC Audit
We successfully defended a national home healthcare provider in appealing an $18 million extrapolated overpayment resulting from a UPIC audit.
Advise a public university system on compliance with the rules associated with grants and contracts from NIH, NSF, and the Department of Defense